Brief: AgeX Therapeutics And Lineage Cell Therapeutics Announce Issuance Of U.S. Patent For Method Of Generating Induced Pluripotent Stem Cells
Dec 10 (Reuters) - AgeX Therapeutics Inc AGE.A :
* AGEX THERAPEUTICS AND LINEAGE CELL THERAPEUTICS ANNOUNCE
ISSUANCE OF U.S. PATENT FOR METHOD OF GENERATING INDUCED
PLURIPOTENT STEM CELLS
Source text for Eikon: ID:nBw2ZmVMLa
Further company coverage: AGE.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Lineage Cell Therapeutics
See all newsLineage Cell Therapeutics Q2 revenue falls but posts profit
Brief: Lineage Cell Therapeutics Q2 Income From Operations USD -8.923 Million
Lineage Cell Therapeutics Q1 net loss widens as expenses rise
Lineage Cell Q4 revenue rises on Genentech collaboration
Brief: Lineage Cell Therapeutics FY Income From Operations USD -36.619 Million